We came across a bullish thesis on Sarepta Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support ...

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from ...